Search results
Find the latest (ZLCS) stock quote, history, news and other vital information to help you with your stock trading and investing.
19 mar 2012 · zlcs will be a target for buyout as soon as possible. Z-160 is a Big Thing. I think target price will be $4-$7. GLTA
EPIRUS Biopharmaceuticals serves customers worldwide. Company profile page for EPIRUS Biopharmaceuticals Inc including stock price, company news, executives, board members, and contact...
Interactive Chart for (ZLCS), analyze all the data with a huge range of indicators.
16 kwi 2014 · The merger will create a publicly-traded company listed on the NASDAQ. Zalicus (ZLCS) soared Wednesday after the biopharmaceutical company announced it would merge with Epirus Biopharmaceuticals.
28 mar 2011 · Early Friday morning, JMP Securities issued a "Market Outperform" rating for Zalicus Inc. (ZLCS) and a "target" of $5 per share. Shares jumped 5%-6% on the JMP Securities news following the...
ZLCS - Forecast, Price Target, Estimates, Predictions. ... Highest Cost to Borrow; Highest Short Float; Owners Retail Ownership Most Popular Funds Activist Investors Fund Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand.
